Dan Lu

7PUBLICATIONS
9CO-AUTHORS
Deep learningPredictive and prognostic markersPharmacogenomicsImmunology not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 11, 2024
Deep-NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data.

Gengbo Liu, Logan Brooks, John Canty

|Oct 04, 2022
Applying interpretable machine learning workflow to evaluate exposure-response relationships for large-molecule oncology drugs.

Gengbo Liu, James Lu, Hong Seo Lim

|Aug 21, 2022
Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure-response relationships for large-molecule oncology drugs.

Victor Poon, Dan Lu

|Dec 01, 2020
Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma.

Dan Lu, Tong Lu, Rong Shi

|Aug 10, 2020
Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

Rong Shi, Tong Lu, Grace Ku

|Jul 24, 2020
An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias.

Jennifer L Wilson, Dan Lu, Nick Corr

Pageof 2

Frequent Collaborators

3 joint publications

James Lu

2 joint publications

Gengbo Liu

2 joint publications

Jin Yan Jin

1 joint publications

Tong Lu